Manufacturer record
Kite Formulation: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Kite Formulation was declared Not of Standard Quality in April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 1124192, Merocet (Cetirizine Hydrochloride Syrup) (exp Oct 2026). DTL Madurai (state lab) found it not of standard quality: Sample does not conform to IP specification with respect to the PH. Listed in the April 2025 alert.
Records by type
1 record linked to Kite Formulation in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Merocet (Cetirizine Hydrochloride Syrup) | Batch 1124192Mfg Nov 2024 · Exp Oct 2026 | Sample does not conform to IP specification with respect to the PH.pH | DTL MaduraiState lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.